Clinical value of Canephron N after surgical treatment of urinary stone disease


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Background. The drug Canephron N is a combination of extracts of centaury, lovage and rosemary. Moderate antispasmoic, antiinflammatory, antioxidant, diuretic and antimicrobial effects are of great interest for urological practice. The optimal combination of components that were made of herbal medicine allows to use their synergistic effect for prevention of recurrence of urinary stone disease. The experience of using the drug Canephron in clinical practice is of great interest. Aim: to clarify the clinical efficiency of Canephron N in patients with urinary stone disease after surgical treatment and to evaluate the changes in diuresis and calcium excretion. Materials and methods: The results of using the drug Canephron after surgical treatment of urinary stone disease are provided. The changes in diuresis and calcium excretion in 75 patients undergone surgical treatment of urinary stone disease were studied. Patients after ureteroscopy, percutaneous nephrolithotomy and extracorporeal shockwave lithotripsy were prescribed treatment to prevent stone formation including herbal drug Canephron N. Results. At baseline, there was negative correlation between 24-hours diuresis and calcium excretion in all groups. During follow-up, a positive correlation between 24-hours diuresis and calcium excretion was found in patients receiving Canephron N and other types of treatment. The average follow-up was 390 days. During this period, recurrence was noted in 1 patient receiving Canephron, 4 patients in patients who took other drugs and in 5 patients who didn’t receive any treatment. Conclusion. Risk factors of stone formation persist after surgical treatment of urinary stone disease. This is reflected in a negative correlation between 24-hour diuresis and calcium excretion. During treatment, a positive correlation between diuresis and calcium excretion was noted in patients with urinary stone disease. The use of drugs that affect stone formation as well as herbal medicine Canephron N allow to obtain comparable ratio of diuresis and calcium excretion.

Full Text

Restricted Access

About the authors

Yu. L Demidko

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: demidko1@mail.ru
MD, urologist at the LDO №4 UKB №2

V. I Rudenko

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: rudenko-vadim@rambler.ru
MD, professor at the Clinic of Urology and Male Reproductive Health

V. A Grigoryan

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: doctor-grigoryan@mail.ru
MD, professor at the Clinic of Urology and Male Reproductive Health

M. E Enikeev

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: enikmic@mail.ru
MD, professor at the Clinic of Urology and Male Reproductive Health

S. N Allenov

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: med-allen@yandex.ru
Head of LDO №4 UKB №2

I. G Kasiteridi

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: kasgr@rambler.ru
urologist at the LDO №4 UKB №2

T. A Ujegov

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: uzhik1812@mail.ru
urologist at the LDO №4 UKB №2

A. V Amosov

FGAOU VO I.M. Sechenov First Moscow State Medical University of Minzdrav of Russia

Email: amosov-av@yandex.ru
MD, professor at the Clinic of Urology and Male Reproductive Health

References

  1. Kasote D.M., Jagtap S.D., Thapa D., Khyade M.S., Russell W.R. 2017. Herbal remedies for urinary stones used in India and China: A review. J. Ethnopharmacol. 2017;203:55-68.
  2. Sadki C., Atmani F. 2017. Evaluation of antilithiasic, oxalo-calcic and magnesium ammonium phosphate effect of Erica multiflora L. aqueous extract. Prog Urol. 2017;27(16):1058-1067.
  3. Яровой С.К. Применение растительных терпенов в комплексном лечении и метафилактике мочекаменной болезни. Урологические ведомости. 2013. Т. 3
  4. Пронченко Г.Е. Лекарственные растительные средства. М.: ГЭОТАР-МЕД, 2003
  5. Шаплыгин Л.В., Монаков Ц.М. Канефрон Н. в лечении и профилактике мочекаменной болезни. Урология. 2006;8
  6. Перепанова Т.С., Дзеранов Н.К. Принципы противовоспалительной терапии при МКБ. Пленум правления РОУ. Москва, 2003
  7. Лопаткин Н.А. 2009. Урология. Национальное руководство. М.: ГЭОТАР-МЕД, 2009
  8. Сивков А.В., Черепанова Е.В., Шадеркина В.А. Применение фитопрепаратов на основе терпенов при мочекаменной болезни. Экспериментальная и клиническая урология. 2011;1:69-72
  9. Амосов А.В., Аляев Ю.Г., Саенко В.С. Растительный лекарственный препарат канефрон н в послеоперационной метафилактике мочекаменной болезни. Урология. 2010;5:65-71
  10. Сукало А.В., Крохина С.А., Тур Н.И. Первый опыт применения препарата канефрон н в лечении дизметаболических нефропатий у детей. Рецепт. 2006;5:70-73
  11. Гресь А.А., Вощула В.И., Рыбина И.Л. и соавт., 2004. Мочекаменная болезнь: опыт применения и эффективность Канефрона Н. Медицинские новости. 2004;8:89-93
  12. Аляев Ю.Г., Руденко В.И., Саенко В.С., Дзеранов Н.К., Амосов А.В. Растительный препарат Канефрон Н. в лечении больных мочекаменной болезнью. Урология. 2012;6:22-25

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies